Sir Peng Khaw

This user account status is Approved

Developing new therapies for glaucomatous optic neuropathy and in particular for preventing scarring and for regeneration, Developed surgical techniques (Moorfields Safer Surgery System) which have improved the safety and outcomes of antimetabolite assisted trabeculectomy and developed new anti-scarring regimens based on laboratory research, which led to international clinical trials. Currently involved in developing new anti-scarring drugs and delivery systems, as well as drainage devices, and has proposed the 10-10-10 challenge for glaucoma: an intraocular pressure of 10 mmHg for 10 years, done in 10 minutes.

Professor of Glaucoma and Ocular Healing, and Consultant Ophthalmic Surgeon
Sir Peng
United Kingdom

NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology

Director, UK National Institute for Health Research Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK; Director, Research & Development, Moorfields Eye Hospital, London, UK; Programme Director Eyes & Vision, UCL Partners, London, UK. Past President of ARVO. Chair Eye Health Group, WISH Foundation.


Wednesday 3.00 pm-4.30 pmPlenary 2

New frontiers in glaucoma

Chair(s): Janet Serle (United States); Peng Khaw (United Kingdom);

Thursday 1.45 pm-3.15 pmRoom 210 & 211

Congenital Pediatric Glaucoma

Chair(s): Cecilia Fenerty (United Kingdom); Alana Grajewski (United States); Ching Lin Ho (Singapore);



Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

MCI Amsterdam
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands